Texas Roadhouse, Inc. (TXRH) Stock Forecast
Data as of Jul 31, 2026Consumer Cyclical · Current price $205.89 (-1.11%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Apr 16, 2026 | Zachary Fadem | Wells Fargo | $200.00 | -2.9% |
| Feb 20, 2026 | Jake Bartlett | Truist Financial | $186.00 | -9.7% |
| Feb 20, 2026 | Andrew Strelzik | BMO Capital | $165.00 | -19.9% |
| Jan 20, 2026 | Brian Harbour | Morgan Stanley | $208.00 | +1.0% |
| Jan 7, 2026 | Jeffrey Bernstein | Bernstein | $185.00 | -10.1% |
| Dec 17, 2025 | Zachary Fadem | Wells Fargo | $195.00 | -5.3% |
| Oct 27, 2025 | Nick Setyan | Mizuho Securities | $190.00 | -7.7% |
| Oct 21, 2025 | Brian Harbour | Morgan Stanley | $210.00 | +2.0% |
| Jul 25, 2025 | Chris O'Cull | Stifel Nicolaus | $188.00 | -8.7% |
| May 5, 2025 | Dennis Geiger | UBS | $200.00 | -2.9% |
| Apr 15, 2025 | Chris O'Cull | Stifel Nicolaus | $170.00 | -17.4% |
| Apr 7, 2025 | David Tarantino | Robert W. Baird | $180.00 | -12.6% |
| Jan 8, 2025 | Jake Bartlett | Truist Financial | $209.00 | +1.5% |
| Oct 15, 2024 | David Palmer | Evercore ISI | $200.00 | -2.9% |
| Jul 26, 2024 | Andrew Strelzik | BMO Capital | $155.00 | -24.7% |
| Jul 26, 2024 | Jim Salera | Stephens | $176.00 | -14.5% |
| Jul 16, 2024 | Brian Harbour | Morgan Stanley | $162.00 | -21.3% |
| Jul 15, 2024 | Jim Salera | Stephens | $170.00 | -17.4% |
| Jul 1, 2024 | Jake Bartlett | Truist Financial | $183.00 | -11.1% |
| Jun 7, 2024 | Christopher Carril | RBC Capital | $175.00 | -15.0% |
Top Analysts Covering TXRH
TXRH vs Sector & Market
| Metric | TXRH | Consumer Cyclical Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.57 | 2.50 | 2.42 |
| Analyst Count | 23 | 12 | 19 |
| Target Upside | -0.1% | +132.9% | +18.0% |
| P/E Ratio | 32.89 | 17.38 | 43.33 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-30 | $6.48B | $6.54B | $6.58B | 21 |
| 2027-03-30 | $1.76B | $1.78B | $1.80B | 8 |
| 2027-06-30 | $1.79B | $1.82B | $1.84B | 8 |
| 2027-09-30 | $1.71B | $1.73B | $1.75B | 11 |
| 2027-12-30 | $1.76B | $1.79B | $1.80B | 8 |
| 2028-03-30 | $1.90B | $1.93B | $1.95B | 9 |
| 2028-06-30 | $1.94B | $1.96B | $1.98B | 7 |
| 2028-09-30 | $1.84B | $1.87B | $1.88B | 14 |
| 2028-12-30 | $1.89B | $1.92B | $1.94B | 8 |
| 2029-12-30 | $8.08B | $8.25B | $8.35B | 5 |
| 2030-12-30 | $8.89B | $9.08B | $9.19B | 5 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-30 | $6.09 | $6.29 | $6.50 | 21 |
| 2027-03-30 | $2.11 | $2.15 | $2.18 | 8 |
| 2027-06-30 | $2.04 | $2.08 | $2.11 | 8 |
| 2027-09-30 | $1.60 | $1.63 | $1.65 | 8 |
| 2027-12-30 | $1.73 | $1.76 | $1.78 | 15 |
| 2028-03-30 | $2.55 | $2.60 | $2.63 | 15 |
| 2028-06-30 | $2.44 | $2.49 | $2.52 | 11 |
| 2028-09-30 | $1.92 | $1.96 | $1.99 | 9 |
| 2028-12-30 | $2.07 | $2.11 | $2.13 | 9 |
| 2029-12-30 | $9.42 | $9.69 | $9.84 | 3 |
| 2030-12-30 | $10.66 | $10.96 | $11.13 | 2 |
Frequently Asked Questions
What is the analyst consensus for TXRH?
The consensus among 23 analysts covering Texas Roadhouse, Inc. (TXRH) is Hold with an average price target of $191.46.
What is the highest price target for TXRH?
The highest price target for TXRH is $210.00, set by Brian Harbour at Morgan Stanley on 2025-10-21.
What is the lowest price target for TXRH?
The lowest price target for TXRH is $95.00, set by James Rutherford at Stephens on 2021-10-19.
How many analysts cover TXRH?
23 analysts have issued ratings for Texas Roadhouse, Inc. in the past 12 months.
Is TXRH a buy or sell right now?
Based on 23 analyst ratings, TXRH has a consensus rating of Hold (2.57/5) with a -0.1% upside to the consensus target of $191.46.
What are the earnings estimates for TXRH?
Analysts estimate TXRH will report EPS of $6.29 for the period ending 2026-12-30, with revenue estimated at $6.54B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.